Attracting preferred investigators and winning their participation in clinical trials requires careful planning and execution by study sponsors. CRO and pharmaceutical executives must preserve and promote relationships with investigators to efficiently acquire high quality data during a study. This 32-page document will help pharmaceutical and CRO executives better position their studies to recruit top investigators and keep those investigators loyal.
- relationship management
- protocol involvement
- services and training.
Sample Best Practices
1.Supply customized patient recruitment support to increase investigator satisfaction and meet enrollment targets.
-For example, one investigator stated that the ideal relationship is to have a national patient recruitment organization do advertisements with a screening questionnaire before a site takes the resulting referrals.
2.Create a two-tiered process for protocol review to ensure protocols are designed for both scientific value and ease of completion.
- One benchmark partner’s clinical science group may bring KOLs in for an advisory board meeting to draft a protocol from the very beginning. After the draft protocol is in place, regional managers then bring it to about six key investigators seeking insight on potential challenges to patient enrollment.
3. Provide study coordinators with training and opportunities to participate in advisory boards to win their loyalty to clinical trials.
-One company uses meetings, symposia and other such tactics to acknowledge the contributions that study coordinators make.
This research originated from a Best Practices, LLC consulting project. It was conducted for a pharmaceutical client and was based on interviews and surveys with pharmaceutical, CRO and investigative site benchmark partners.